Publications by authors named "W Andrew Yeudall"

Polyriboinosinic acid-polyribocytidylic acid (Poly I:C) serves as a synthetic mimic of viral double-stranded dsRNA, capable of inducing apoptosis in numerous cancer cells. Despite its potential, therapeutic benefits, the application of Poly I:C has been hindered by concerns regarding toxicity, stability, enzymatic degradation, and undue immune stimulation, leading to autoimmune disorders. To address these challenges, encapsulation of antitumor drugs within delivery systems such as cationic liposomes is often employed to enhance their efficacy while minimizing dosages.

View Article and Find Full Text PDF
Article Synopsis
  • Lung cancer remains the most common and deadly cancer globally, with current treatments only partially effective, highlighting the need for better options.
  • Angiogenesis and cancer stem cells are key contributors to cancer development, and existing anti-angiogenic treatments have limitations and side effects.
  • Inhalant cannabidiol (CBD) was tested in mice with lung cancer, showing that it reduced tumor growth and suppressed important factors linked to cancer progression, suggesting its potential as a new treatment.
View Article and Find Full Text PDF

In advanced metastatic cancers with reduced patient survival and poor prognosis, expression of vimentin, a type III intermediate filament protein is frequently observed. Vimentin appears to suppress epithelial characteristics and augments cell migration but the molecular basis for these changes is not well understood. Here, we have ectopically expressed vimentin in MCF-7 and investigated its genomic and functional implications.

View Article and Find Full Text PDF

Glioblastoma (GBM) is the most common invasive brain tumor composed of diverse cell types with poor prognosis. The highly complex tumor microenvironment (TME) and its interaction with tumor cells play important roles in the development, progression, and durability of GBM. Angiogenic and immune factors are two major components of TME of GBM; their interplay is a major determinant of tumor vascularization, immune profile, as well as immune unresponsiveness of GBM.

View Article and Find Full Text PDF